BMRN · BioMarin Pharmaceutical Inc. Common Stock
View on chartInsiders & Stakes
| Jean Jacques Bienaime Chief Executive Officer | ▼ Sell | Tax Withholding | 473,792 Shares held | 5/20/2024 | View profile |
| Alexander Hardy Chief Executive Officer | ▼ Sell | Tax Withholding | 214,635 Shares held | 3/17/2026 | View profile |
| FUCHS HENRY J President, Worldwide R&D | ▼ Sell | Tax Withholding | 185,074 Shares held | 9/13/2024 | View profile |
| Richard A. Meier Director | ▲ Buy | Grant | 127,426 Shares held | 5/20/2025 | View profile |
| Brian Mueller EVP, Chief Financial Officer | ▼ Sell | Tax Withholding | 123,314 Shares held | 3/17/2026 | View profile |
| Elaine J. Heron Director | ▼ Sell | Tax Withholding | 97,720 Shares held | 6/3/2024 | View profile |
| Charles Greg Guyer EVP, Chief Technical Officer | ▼ Sell | Tax Withholding | 84,140 Shares held | 3/17/2026 | View profile |
| Ajer Jeffrey Robert EVP, Chief Commercial Officer | ▼ Sell | Open Market | 66,767 Shares held | 5/2/2024 | View profile |
| George Eric Davis EVP, General Counsel | ▼ Sell | Open Market | 61,003 Shares held | 9/2/2026 | View profile |
| David E. I. Pyott Director | ▲ Buy | Grant | 49,750 Shares held | 5/21/2024 | View profile |
| Robert J. Hombach Director | ▲ Buy | Grant | 49,360 Shares held | 6/2/2026 | View profile |
| Gregory R. Friberg EVP, Chief R&D Officer | ▼ Sell | Tax Withholding | 47,732 Shares held | 9/30/2026 | View profile |
| Willard H. Dere Director | ▲ Buy | Grant | 46,440 Shares held | 6/2/2026 | View profile |
| Cristin Hubbard EVP, Chief Commercial Officer | ▼ Sell | Tax Withholding | 42,472 Shares held | 5/20/2026 | View profile |
| Elizabeth M. Anderson Director | ▲ Buy | Grant | 41,940 Shares held | 6/2/2026 | View profile |
| Maykin Ho Director | ▲ Buy | Grant | 35,500 Shares held | 6/2/2026 | View profile |
| V. Bryan Lawlis Director | ▲ Buy | Grant | 33,140 Shares held | 5/23/2023 | View profile |
| Slamon Dennis Director | ▼ Sell | Tax Withholding | 31,299 Shares held | 3/18/2024 | View profile |
| Rashmi Virendra Ramchandani VP, Chief Accounting Officer | ▲ Buy | Grant | 25,610 Shares held | 1/20/2026 | View profile |
| Barbara W. Bodem Director | ▲ Buy | Grant | 21,045 Shares held | 6/2/2026 | View profile |
| Athena Countouriotis Director | ▲ Buy | Grant | 21,040 Shares held | 6/2/2026 | View profile |
| Mark J. Enyedy Director | ▲ Buy | Grant | 21,040 Shares held | 6/2/2026 | View profile |
| Timothy P. Walbert Director | ▲ Buy | Grant | 17,270 Shares held | 6/2/2026 | View profile |
| Alles Mark J Director | ▲ Buy | Grant | 15,095 Shares held | 5/23/2023 | View profile |
| Ian T. Clark Director | ▲ Buy | Grant | 14,490 Shares held | 6/2/2026 | View profile |
| Burkhart Erin SVP, Controllership | ▼ Sell | Open Market | 14,173 Shares held | 5/20/2025 | View profile |
| Robert M. Plenge Director | ▲ Buy | Grant | 6,140 Shares held | 9/10/2026 | View profile |
Transaction History
| Gregory R. Friberg | ▼ Sell | Tax Withholding | 4,086 | $245K | 9/30/2026 |
| Robert M. Plenge | ▲ Buy | Grant | 6,140 | $0 | 9/10/2026 |
| George Eric Davis | ▼ Sell | Open Market | 17,557 | $1.2M | 9/2/2026 |
| Athena Countouriotis | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Timothy P. Walbert | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Maykin Ho | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Robert J. Hombach | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Mark J. Enyedy | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Willard H. Dere | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Ian T. Clark | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Barbara W. Bodem | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Elizabeth M. Anderson | ▲ Buy | Grant | 7,490 | $0 | 6/2/2026 |
| Cristin Hubbard | ▼ Sell | Tax Withholding | 2,318 | $116K | 5/20/2026 |
| Gregory R. Friberg | ▼ Sell | Open Market | 3,281 | $177K | 5/7/2026 |
| George Eric Davis | ▼ Sell | Tax Withholding | 1,273 | $71K | 3/18/2026 |
| Cristin Hubbard | ▼ Sell | Tax Withholding | 1,245 | $70K | 3/17/2026 |
| Gregory R. Friberg | ▼ Sell | Tax Withholding | 1,629 | $91K | 3/17/2026 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 1,693 | $95K | 3/17/2026 |
| Brian Mueller | ▼ Sell | Tax Withholding | 2,117 | $119K | 3/17/2026 |
| Alexander Hardy | ▼ Sell | Tax Withholding | 4,252 | $238K | 3/17/2026 |
| Gregory R. Friberg | ▲ Buy | Grant | 19,150 | $0 | 3/16/2026 |
| Cristin Hubbard | ▲ Buy | Grant | 15,410 | $0 | 3/16/2026 |
| Charles Greg Guyer | ▲ Buy | Grant | 14,990 | $0 | 3/16/2026 |
| George Eric Davis | ▼ Sell | Tax Withholding | 7,177 | $420K | 3/16/2026 |
| George Eric Davis | ▲ Buy | Grant | 14,570 | $0 | 3/16/2026 |
| Alexander Hardy | ▲ Buy | Grant | 62,440 | $0 | 3/16/2026 |
| Brian Mueller | ▲ Buy | Grant | 18,740 | $0 | 3/16/2026 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 9,109 | $533K | 3/13/2026 |
| Brian Mueller | ▼ Sell | Tax Withholding | 9,945 | $582K | 3/13/2026 |
| Alexander Hardy | ▼ Sell | Tax Withholding | 2,941 | $172K | 3/13/2026 |
| Charles Greg Guyer | ▼ Sell | Open Market | 16,486 | $997K | 3/11/2026 |
| Gregory R. Friberg | ▼ Sell | Open Market | 6,326 | $382K | 2/26/2026 |
| George Eric Davis | ▼ Sell | Open Market | 26,061 | $1.6M | 2/26/2026 |
| Charles Greg Guyer | ▲ Buy | Grant | 6,176 | $0 | 2/25/2026 |
| Charles Greg Guyer | ▲ Buy | Grant | 6,675 | $0 | 2/25/2026 |
| Charles Greg Guyer | ▲ Buy | Grant | 2,371 | $0 | 2/25/2026 |
| George Eric Davis | ▲ Buy | Grant | 6,177 | $0 | 2/25/2026 |
| George Eric Davis | ▲ Buy | Grant | 6,675 | $0 | 2/25/2026 |
| George Eric Davis | ▲ Buy | Grant | 2,372 | $0 | 2/25/2026 |
| Brian Mueller | ▲ Buy | Grant | 6,683 | $0 | 2/25/2026 |
| Brian Mueller | ▲ Buy | Grant | 7,230 | $0 | 2/25/2026 |
| Brian Mueller | ▲ Buy | Grant | 2,569 | $0 | 2/25/2026 |
| Rashmi Virendra Ramchandani | ▲ Buy | Grant | 18,540 | $0 | 1/20/2026 |
| Rashmi Virendra Ramchandani | ▲ Buy | Grant | 7,070 | $0 | 1/20/2026 |
| Alexander Hardy | ▼ Sell | Tax Withholding | 16,570 | $912K | 12/1/2025 |
| Gregory R. Friberg | ▼ Sell | Tax Withholding | 3,304 | $179K | 9/30/2025 |
| Ian T. Clark | ▲ Buy | Grant | 7,000 | $0 | 8/1/2025 |
| Maykin Ho | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Mark J. Enyedy | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Willard H. Dere | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Cristin Hubbard | ▼ Sell | Tax Withholding | 2,155 | $129K | 5/20/2025 |
| Timothy P. Walbert | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Richard A. Meier | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Robert J. Hombach | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Athena Countouriotis | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Barbara W. Bodem | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Elizabeth M. Anderson | ▲ Buy | Grant | 6,650 | $0 | 5/20/2025 |
| Burkhart Erin | ▼ Sell | Open Market | 1,786 | $106K | 5/20/2025 |
| Burkhart Erin | ▼ Sell | Tax Withholding | 996 | $59K | 5/19/2025 |
| Cristin Hubbard | ▼ Sell | Open Market | 273 | $18K | 5/2/2025 |
| Alexander Hardy | ▲ Buy | Grant | 375 | $20K | 4/30/2025 |
| Cristin Hubbard | ▲ Buy | Grant | 273 | $15K | 4/30/2025 |
| Burkhart Erin | ▼ Sell | Open Market | 1,295 | $93K | 3/19/2025 |
| George Eric Davis | ▲ Buy | Grant | 12,940 | $0 | 3/17/2025 |
| Cristin Hubbard | ▲ Buy | Grant | 13,310 | $0 | 3/17/2025 |
| Charles Greg Guyer | ▲ Buy | Grant | 13,310 | $0 | 3/17/2025 |
| Brian Mueller | ▲ Buy | Grant | 16,640 | $0 | 3/17/2025 |
| Alexander Hardy | ▲ Buy | Grant | 44,360 | $0 | 3/17/2025 |
| Gregory R. Friberg | ▲ Buy | Grant | 17,750 | $0 | 3/17/2025 |
| Burkhart Erin | ▲ Buy | Grant | 5,970 | $0 | 3/17/2025 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 20,127 | $1.4M | 3/14/2025 |
| Brian Mueller | ▼ Sell | Tax Withholding | 18,497 | $1.3M | 3/14/2025 |
| Alexander Hardy | ▼ Sell | Tax Withholding | 2,933 | $204K | 3/14/2025 |
| Burkhart Erin | ▼ Sell | Tax Withholding | 823 | $57K | 3/14/2025 |
| George Eric Davis | ▼ Sell | Tax Withholding | 16,249 | $1.1M | 3/14/2025 |
| Charles Greg Guyer | ▼ Sell | Open Market | 7,034 | $501K | 3/6/2025 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 4,287 | $305K | 2/28/2025 |
| Charles Greg Guyer | ▲ Buy | Grant | 11,040 | $0 | 2/25/2025 |
| Charles Greg Guyer | ▲ Buy | Grant | 9,367 | $0 | 2/25/2025 |
| George Eric Davis | ▲ Buy | Grant | 9,367 | $0 | 2/25/2025 |
| Charles Greg Guyer | ▲ Buy | Grant | 9,660 | $0 | 2/25/2025 |
| George Eric Davis | ▲ Buy | Grant | 11,040 | $0 | 2/25/2025 |
| George Eric Davis | ▲ Buy | Grant | 9,660 | $0 | 2/25/2025 |
| Brian Mueller | ▲ Buy | Grant | 11,040 | $0 | 2/25/2025 |
| Brian Mueller | ▲ Buy | Grant | 9,660 | $0 | 2/25/2025 |
| Brian Mueller | ▲ Buy | Grant | 9,367 | $0 | 2/25/2025 |
| Timothy P. Walbert | ▲ Buy | Grant | 3,130 | $0 | 2/24/2025 |
| Burkhart Erin | ▼ Sell | Open Market | 1,344 | $92K | 2/24/2025 |
| Alexander Hardy | ▼ Sell | Tax Withholding | 14,295 | $944K | 11/29/2024 |
| Charles Greg Guyer | ▼ Sell | Open Market | 5,278 | $350K | 11/12/2024 |
| Alexander Hardy | ▲ Buy | Grant | 300 | $17K | 10/31/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 55 | $3K | 10/31/2024 |
| Gregory R. Friberg | ▲ Buy | Grant | 21,190 | $0 | 9/30/2024 |
| Gregory R. Friberg | ▲ Buy | Grant | 7,870 | $0 | 9/30/2024 |
| FUCHS HENRY J | ▼ Sell | Tax Withholding | 12,098 | $1.0M | 9/13/2024 |
| Burkhart Erin | ▼ Sell | Open Market | 714 | $64K | 8/13/2024 |
| Brian Mueller | ▼ Sell | Tax Withholding | 588 | $48K | 6/28/2024 |
| Elaine J. Heron | ▲ Buy | Option Exercise | 5,047 | $318K | 6/3/2024 |
| Richard A. Meier | ▲ Buy | Option Exercise | 6,600 | $416K | 6/3/2024 |
| Elaine J. Heron | ▼ Sell | Tax Withholding | 4,168 | $318K | 6/3/2024 |
| Richard A. Meier | ▼ Sell | Tax Withholding | 5,451 | $417K | 6/3/2024 |
| Brian Mueller | ▲ Buy | Option Exercise | 5,000 | $316K | 5/30/2024 |
| Brian Mueller | ▼ Sell | Open Market | 5,000 | $376K | 5/30/2024 |
| George Eric Davis | ▲ Buy | Option Exercise | 40,850 | $2.6M | 5/28/2024 |
| George Eric Davis | ▼ Sell | Open Market | 38,071 | $2.8M | 5/28/2024 |
| George Eric Davis | ▼ Sell | Open Market | 2,779 | $209K | 5/28/2024 |
| Barbara W. Bodem | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Mark J. Enyedy | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Willard H. Dere | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Athena Countouriotis | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Elizabeth M. Anderson | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| David E. I. Pyott | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Richard A. Meier | ▲ Buy | Grant | 7,080 | $0 | 5/21/2024 |
| Robert J. Hombach | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Maykin Ho | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Elaine J. Heron | ▲ Buy | Grant | 4,720 | $0 | 5/21/2024 |
| Cristin Hubbard | ▲ Buy | Grant | 14,690 | $0 | 5/20/2024 |
| Cristin Hubbard | ▲ Buy | Grant | 4,700 | $0 | 5/20/2024 |
| Jean Jacques Bienaime | ▼ Sell | Tax Withholding | 1,202 | $93K | 5/20/2024 |
| Burkhart Erin | ▼ Sell | Tax Withholding | 993 | $76K | 5/17/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 20,000 | $1.6M | 5/10/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 20,000 | $1.3M | 5/10/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 20,000 | $1.3M | 5/9/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 20,000 | $1.6M | 5/9/2024 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 4,440 | $366K | 5/3/2024 |
| George Eric Davis | ▲ Buy | Option Exercise | 1,850 | $117K | 5/2/2024 |
| George Eric Davis | ▼ Sell | Open Market | 1,850 | $157K | 5/2/2024 |
| Ajer Jeffrey Robert | ▼ Sell | Open Market | 5,000 | $415K | 5/2/2024 |
| George Eric Davis | ▲ Buy | Grant | 301 | $21K | 4/30/2024 |
| FUCHS HENRY J | ▲ Buy | Grant | 300 | $21K | 4/30/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 245 | $17K | 4/30/2024 |
| Ajer Jeffrey Robert | ▲ Buy | Grant | 300 | $21K | 4/30/2024 |
| Brian Mueller | ▲ Buy | Grant | 300 | $21K | 4/30/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 20,000 | $1.8M | 4/12/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 20,000 | $1.3M | 4/12/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 20,000 | $1.8M | 4/11/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 20,000 | $1.3M | 4/11/2024 |
| Burkhart Erin | ▼ Sell | Open Market | 2,286 | $206K | 4/10/2024 |
| George Eric Davis | ▼ Sell | Open Market | 24,602 | $2.2M | 3/28/2024 |
| Slamon Dennis | ▼ Sell | Tax Withholding | 9,510 | $797K | 3/18/2024 |
| Burkhart Erin | ▼ Sell | Tax Withholding | 372 | $31K | 3/18/2024 |
| Slamon Dennis | ▲ Buy | Option Exercise | 10,000 | $797K | 3/18/2024 |
| George Eric Davis | ▲ Buy | Grant | 10,260 | $0 | 3/15/2024 |
| George Eric Davis | ▼ Sell | Tax Withholding | 21,699 | $1.8M | 3/15/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 10,550 | $0 | 3/15/2024 |
| Charles Greg Guyer | ▼ Sell | Tax Withholding | 20,424 | $1.7M | 3/15/2024 |
| Burkhart Erin | ▲ Buy | Grant | 4,720 | $0 | 3/15/2024 |
| Brian Mueller | ▲ Buy | Grant | 11,400 | $0 | 3/15/2024 |
| Brian Mueller | ▼ Sell | Tax Withholding | 20,789 | $1.7M | 3/15/2024 |
| FUCHS HENRY J | ▲ Buy | Grant | 18,240 | $0 | 3/15/2024 |
| FUCHS HENRY J | ▼ Sell | Tax Withholding | 33,485 | $2.8M | 3/15/2024 |
| Alexander Hardy | ▲ Buy | Grant | 32,780 | $0 | 3/15/2024 |
| Jean Jacques Bienaime | ▼ Sell | Tax Withholding | 85,209 | $7.1M | 3/15/2024 |
| Ajer Jeffrey Robert | ▼ Sell | Tax Withholding | 22,580 | $1.9M | 3/15/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 1,000 | $87K | 3/6/2024 |
| Ajer Jeffrey Robert | ▼ Sell | Open Market | 4,000 | $348K | 3/5/2024 |
| FUCHS HENRY J | ▼ Sell | Open Market | 35,341 | $3.0M | 3/5/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 1,000 | $86K | 3/5/2024 |
| Ajer Jeffrey Robert | ▲ Buy | Grant | 9,338 | $0 | 2/27/2024 |
| Ajer Jeffrey Robert | ▲ Buy | Grant | 6,465 | $0 | 2/27/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 6,284 | $0 | 2/27/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 20,840 | $0 | 2/27/2024 |
| FUCHS HENRY J | ▲ Buy | Grant | 30,640 | $0 | 2/27/2024 |
| George Eric Davis | ▲ Buy | Grant | 6,284 | $0 | 2/27/2024 |
| George Eric Davis | ▲ Buy | Grant | 9,063 | $0 | 2/27/2024 |
| FUCHS HENRY J | ▲ Buy | Grant | 13,326 | $0 | 2/27/2024 |
| Brian Mueller | ▲ Buy | Grant | 20,220 | $0 | 2/27/2024 |
| Brian Mueller | ▲ Buy | Grant | 8,802 | $0 | 2/27/2024 |
| Brian Mueller | ▲ Buy | Grant | 6,103 | $0 | 2/27/2024 |
| Jean Jacques Bienaime | ▲ Buy | Grant | 82,700 | $0 | 2/27/2024 |
| Jean Jacques Bienaime | ▲ Buy | Grant | 35,975 | $0 | 2/27/2024 |
| Jean Jacques Bienaime | ▲ Buy | Grant | 24,926 | $0 | 2/27/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 1,000 | $90K | 2/27/2024 |
| Ajer Jeffrey Robert | ▲ Buy | Grant | 21,440 | $0 | 2/27/2024 |
| George Eric Davis | ▲ Buy | Grant | 20,840 | $0 | 2/27/2024 |
| Charles Greg Guyer | ▲ Buy | Grant | 9,063 | $0 | 2/27/2024 |
| FUCHS HENRY J | ▲ Buy | Grant | 9,238 | $0 | 2/27/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 15,000 | $947K | 2/9/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 15,000 | $1.3M | 2/9/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 15,000 | $947K | 2/8/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 15,000 | $1.3M | 2/8/2024 |
| Jean Jacques Bienaime | ▼ Sell | Other | 40 | $4K | 1/18/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 10,000 | $631K | 1/10/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 10,000 | $964K | 1/10/2024 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 10,000 | $631K | 1/9/2024 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 10,000 | $982K | 1/9/2024 |
| Richard A. Meier | ▼ Sell | Gift | 3,000 | $0 | 1/8/2024 |
| Jean Jacques Bienaime | ▼ Sell | Other | 50 | $5K | 1/8/2024 |
| Mark J. Enyedy | ▲ Buy | Grant | 2,180 | $0 | 12/27/2023 |
| Athena Countouriotis | ▲ Buy | Grant | 2,180 | $0 | 12/27/2023 |
| Barbara W. Bodem | ▲ Buy | Grant | 2,180 | $0 | 12/27/2023 |
| Jean Jacques Bienaime | ▲ Buy | Option Exercise | 10,000 | $631K | 12/21/2023 |
| Jean Jacques Bienaime | ▼ Sell | Open Market | 10,000 | $940K | 12/21/2023 |
| George Eric Davis | ▼ Sell | Open Market | 13,764 | $1.3M | 12/13/2023 |
| Jean Jacques Bienaime | ▲ Buy | Grant | 2,370 | $0 | 12/1/2023 |
| Alexander Hardy | ▲ Buy | Grant | 68,039 | $0 | 12/1/2023 |
| Alexander Hardy | ▲ Buy | Grant | 47,332 | $0 | 12/1/2023 |
| Charles Greg Guyer | ▲ Buy | Grant | 11,840 | $0 | 12/1/2023 |
| FUCHS HENRY J | ▲ Buy | Grant | 17,750 | $0 | 12/1/2023 |
| Charles Greg Guyer | ▲ Buy | Grant | 133 | $9K | 10/31/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
BioMarin Reports Phase 3 Pompe Data, Expands AI Partnership
BioMarin presented phase‑3 results for its Pompe disease therapy POMBILITI® combined with OPFOLDA® at the World Muscle Society Congress, reporting sustained efficacy and no new safety signals. The company also announced a partnership with Profluent to use AI for designing enzyme therapies, and a license agreement with Ascendis Pharma that includes royalties on future sales. These developments highlight BioMarin’s focus on expanding its therapeutic pipeline and leveraging technology partnerships.
BioMarin Reports Phase 3 Pompe Data, Expands AI Partnership. BioMarin presented phase‑3 results for its Pompe disease therapy POMBILITI® combined with OPFOLDA® at the World Muscle Society Congress, reporting sustained efficacy and no new safety signals. The company also announced a partnership with Profluent to use AI for designing enzyme therapies, and a license agreement with Ascendis Pharma that includes royalties on future sales. These developments highlight BioMarin’s focus on expanding its therapeutic pipeline and leveraging technology partnerships.